These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27784371)

  • 21. Optimal strategy for obtaining routine chromosome analysis by using negative fractions of CD138 enriched plasma cells.
    Ortega V; Mohamed G; Ehman W; Zhu M; Mendiola C; Velagaleti G
    Cancer Genet; 2016 Mar; 209(3):82-6. PubMed ID: 26797313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
    Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
    J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma.
    Gao X; Li C; Zhang R; Yang R; Qu X; Qiu H; Xu J; Lu H; Li J; Chen L
    Med Oncol; 2012 Sep; 29(3):2200-6. PubMed ID: 21611837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 14q32 translocations and 13q14 deletions are common cytogenetic abnormalities in POEMS syndrome.
    Kang WY; Shen KN; Duan MH; Zhang W; Cao XX; Zhou DB; Li J
    Eur J Haematol; 2013 Dec; 91(6):490-6. PubMed ID: 23957213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia.
    Fröhling S; Skelin S; Liebisch C; Scholl C; Schlenk RF; Döhner H; Döhner K;
    J Clin Oncol; 2002 May; 20(10):2480-5. PubMed ID: 12011125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.
    Schmidt-Hieber M; Gutiérrez ML; Pérez-Andrés M; Paiva B; Rasillo A; Tabernero MD; Sayagués JM; Lopez A; Bárcena P; Sanchez ML; Gutiérrez NC; San Miguel JF; Orfao A
    Haematologica; 2013 Feb; 98(2):279-87. PubMed ID: 22929983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The comparison of three cytogenetic methods for detecting multiple myeloma].
    Ren J; Yang LH; Li GX; Fan JL; Hou J
    Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):737-40. PubMed ID: 20079209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients.
    Hamdaoui H; Benlarroubia O; Ait Boujmia OK; Mossafa H; Ouldim K; Belkhayat A; Smyej I; Benrahma H; Dehbi H; Chegdani F
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1363. PubMed ID: 32573970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of the Cytogenetic Aberrations in Multiple Myeloma by Using Microrray Comparative Genomic Hybridization].
    Wang YF; Wang H; Xi LY; Zhang ZH; Wang J; Dong F; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1389-1395. PubMed ID: 30295256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Retrospective Analysis of Genetics Abnormalities in Patients with Multiple Myeloma].
    Wang CB; Wu J; Yang K; Su M; Zhang HY; Pan YZ; Wu T; Xi R; Bai H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1681-1687. PubMed ID: 30501704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
    Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modified Culture System and Combination of FICTION Could Increase the Detection Rate of Abnormalities in Multiple Myeloma.
    Fu Q; Xie S; Chen J; Huang H
    Ann Clin Lab Sci; 2021 Jan; 51(1):61-72. PubMed ID: 33653782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore.
    Lim AS; Lim TH; See KH; Ng YJ; Tan YM; Choo NS; Lim SX; Yee Y; Lau LC; Tien SL; Sathish K; Tan DC
    Chin Med J (Engl); 2013; 126(10):1872-7. PubMed ID: 23673102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective analysis of cytogenetic and clinical characteristics in patients with multiple myeloma.
    He J; Yang L; Meng X; Wei G; Wu W; Han X; Zheng G; Zheng W; Ye X; Shi J; Xie W; Zhang J; Huang H; Lin M; Cai Z
    Am J Med Sci; 2013 Feb; 345(2):88-93. PubMed ID: 22986611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observation on frequency & clinico-pathological significance of various cytogenetic risk groups in multiple myeloma: an experience from India.
    Kadam Amare PS; Jain H; Nikalje S; Sengar M; Menon H; Inamdar N; Subramanian PG; Gujral S; Shet T; Epari S; Nair R
    Indian J Med Res; 2016 Oct; 144(4):536-543. PubMed ID: 28256461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
    Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and biological characteristics multiple myeloma with 1q21 amplification].
    Zhong S; Li C; Yi S; Qiu L
    Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(8):615-9. PubMed ID: 26932854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.